Introduction
A fundamental challenge during organism's life span is to maintain a functional proteome that can adapt in response to physiological and environmental stresses. The complex coordination of diverse pathways, collectively termed the protein homeostasis (proteostasis) network, provides protein quality control (1) (2) (3) (4) . Proteome maintenance starts at the ribosome, continues by correct folding of the nascent polypeptide chain (5, 6) , and ends with the degradation of damaged and dispensable proteins. Proteostasis mechanisms are interconnected and tightly regulated, consisting of transcription, translation, protein folding, and degradation pathways, such as autophagy and the ubiquitin-proteasome system (UPS) (1) (2) (3) (4) . Misregulation of proteostasis is detrimental for the physiology and life span of organisms and contributes to various age-related diseases, including neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases (7) .
An adaptive stress response known as the unfolded protein response (UPR) prevents the overload of misfolded or aggregation-prone proteins in the lumen of the endoplasmic reticulum (ER) and is an important mechanism of proteostasis. The UPR ER consists of three different branches represented by the sensor proteins inositol-requiring enzyme 1a (IRE1a), activating transcription factor 6 (ATF6), and double-stranded RNA-activated protein kinase-like ER kinase (PERK) (8, 9) . IRE1a is a type 1 transmembrane protein that oligomerizes in response to increased abundance of misfolded proteins in the ER lumen (known as ER stress). Oligomerization of IRE1a leads to trans-autophosphorylation through its cytoplasmic kinase domain. In this activated state, IRE1a shows site-specific endonucleolytic activity, which promotes unconventional splicing of the mRNA encoding X-box binding protein 1 [XBP1; also known as homologous to ATF/CREB1 (HAC1) in yeast]. XBP1 functions as transcription factor promoting the expression of UPR genes (10) . ATF6, in its inactive form, is a transmembrane protein. In ER stress conditions, ATF6 is transported from the ER to the Golgi apparatus and cleaved by Golgi-resident proteases. The cytosolic part of ATF6 moves to the nucleus and activates the transcription of UPR genes (11) . Similar to IRE1a, PERK is a type 1 transmembrane protein with a cytosolic kinase domain. Increased abundance of unfolded proteins in the ER lumen triggers PERK oligomerization, trans-autophosphorylation, and phosphorylation of the a subunit of eukaryotic translation initiation factor-2 (eIF2a). Phosphorylation by PERK inactivates eIF2a, reducing protein synthesis and the protein load in the ER (12) . A cell's ability to handle proteotoxic stress and misfolded proteins in the ER declines with age, which is partly due to decreased activity of these proteostasis mechanisms (13) (14) (15) (16) .
The lumen of the ER is of particular importance for proteostasis because it harbors key components for folding, trafficking, and posttranslational modifications of proteins destined for secretion or incorporation into membranes (17) . Chaperone proteins located in the lumen of the ER, including calreticulin (CALR), immunoglobulin binding protein [BIP; also known as glucose-regulated protein 78 (GRP78) or heat shock 70 kDa protein 5 (HSPA5)], and protein disulfide isomerases (PDIs), are part of an elaborate molecular network that facilitates correct folding, quality control, and alleviation of proteotoxic stress (18, 19) . CALR is a soluble ER chaperone that supports protein folding and prevents protein aggregation in the ER lumen. CALR also delays degradation of polypeptides until they are accurately folded (20) (21) (22) . The Hsp70 family member BIP is described as a master regulator of the ER because it binds and modulates many ER processes and functions, such as the UPR sensor proteins IRE1a, ATF6, and PERK (23) . In nonstressed conditions, BIP binds to the luminal domains of all three UPR sensor proteins and, thereby, maintains them in an inactive state. In the context of ER stress, BIP binds to misfolded proteins to prevent aggregation, and no longer binds to the UPR sensor proteins, which activates the UPR ER (24, 25) . In addition to UPR sensor proteins, BIP also binds to translocon (TLC), a protein complex that forms an ER channel necessary for the translocation of proteins during translation and the retrotranslocation of proteins destined for degradation by the 26S proteasome [a process called ER-associated degradation (ERAD)] (26) . Through binding of TLC, BIP seals the translocation pore to prevent ER Ca 2+ leakage and to maintain ER homeostasis (27, 28) , and thus, TLC is also termed ER Ca 2+ leak channel (29) . PDIs, a class of oxidoreductases in the ER, catalyze disulfide bond formation, isomerization, and reduction of nascent proteins, and bind hydrophobic peptides to assist in correct folding (30, 31) . Thus, PDIs are foldase enzymes with chaperone activity (32) . CALR, BIP, and PDIs directly bind Ca 2+ , which enables their interaction with polypeptides and other chaperones and thereby influences their ability to promote folding of nascent polypeptides (33) . Consequently, these chaperones are highly sensitive to the concentration of ER Ca
2+
, and alterations of ER luminal Ca 2+ increase the abundance of misfolded proteins and activate the UPR ER (34, 35) . These ER chaperones, among others, are important Ca 2+ binding proteins that contribute to optimal ER Ca 2+ storage (33, 36 (48, 49) .
microRNAs-a class of endogenous short (∼21 to 23 nucleotides long) noncoding RNAs-act posttranscriptionally to decrease the abundance of target proteins and, thereby, govern diverse cellular processes from development to death (50) . The interaction of microRNAs with target mRNAs results in translational repression, mRNA degradation, or a combination of both (51) . Individual microRNAs presumably bind to various different mRNAs, resulting in complex posttranscriptional regulation of a diverse set of genes encoding proteins that often lie within specific pathways or cell processes. Thus, microRNAs may have wide-ranging physiological consequences (52) . MicroRNAs that target components of the UPR ER or those that are regulated by genes linked to the UPR ER are extensively reviewed. This literature presents an overview of microRNAs that directly connect to the three branches of the UPR ER and focus on downstream pathways, such as the induction of apoptosis (53) (54) (55) (56) ER Ca 2+ homeostasis relies on the activity of different transmembrane channels and receptors. Among those, SERCA mediates the uptake of Ca 2+ from the cytosol into the ER, re-establishes optimal ER Ca 2+ concentration after triggered Ca 2+ release, and counteracts Ca 2+ leakage from the ER. In mammals, the SERCA protein family is encoded by three genes (SERCA1-3). Each gene gives rise to different splice isoforms, which are expressed in a tissue-specific manner throughout development and in adult organisms. The protein encoded by SERCA2b is found almost ubiquitously throughout tissues and localizes to the ER. In contrast, the protein encoded by SERCA2a is exclusively found in skeletal and heart muscle and functions in the sarcoplasmic reticulum (SR) (58) . Decreased abundance of SERCA2a and decreased SERCA2a-dependent Ca 2+ pumping are associated with pathological conditions of the heart and heart failure (59) .
The abundance of SERCA2a is regulated by at least two different microRNAs. miR-328 was initially described in studies on atrial fibrillation (AF) (60) . AF is a common form of cardiac arrhythmia that is associated with a higher risk of ischemic stroke and can progress into heart failure (61). The abundance of miR-328 is decreased in a mouse model of AF (60) . Transgenic mice stably expressing miR-328 in cardiac tissue display hypertrophic changes, such as enlarged size of the heart, increased appearance of ventricular tissue, and elevated expression of hypertrophic markers such as atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and b-myosin heavy chain (b-MHC), in addition to phenotypes associated with the maladaptive responses to AF (62) . Cardiac hypertrophy occurs in response to damage, aging, or hypertension and initially starts with the enlargement of individual cardiomyocytes and progressive fibrosis, and eventually leads to cell death and progression into heart failure (63). miR-328 directly targets SERCA2a mRNA and thereby reduces the abundance of SERCA2a in mouse cardiomyocytes in vivo and in cultured neonatal rat ventricular myocytes (NRVMs). Stable expression of miR-328 and consequent low abundance of SERCA2a disrupt reuptake of Ca 2+ in isolated mouse cardiomyocytes stimulated with caffeine to induce release of ER Ca
. This prolongs the transient increase of Ca 2+ in the cytosol, which enhances the activation of downstream signaling molecules, such as the phosphatase calcineurin and its target, the transcription factor NFAT (nuclear factor of activated T cells) (62, 64) . Activation of calcineurin and the associated induction of nuclear localization of NFAT stimulate the expression of genes that promote cardiac hypertrophy (65) . The inhibition of miR-328 in mice counteracts the activation of calcineurin and the nuclear localization of NFAT, and attenuates cardiac hypertrophy (62) . miR-25 also directly targets SERCA2a mRNA and reduces the abundance of SERCA2a in human cardiomyocytes (66) . SERCA2a is important for cardiac contractility and is involved in cardiac hypertrophy. SERCA2a determines both the relaxation and the contraction of cardiomyocytes by reducing cytosolic Ca 2+ and controlling SR Ca 2+ load (59) . Stable expression of miR-25 in HL-1 cardiomyocytes, which contract spontaneously (67), delayed Ca 2+ reuptake in the SR after contraction (66) . The abundance of miR-25 is increased in human cardiomyocytes from patients with severe heart failure. Intravenous injection of single-strand oligonucleotides that antagonize miR-25 function in mice with induced heart failure increases the abundance of SERCA2a to normal physiological amounts and improves cardiac function (66) . Thus, miR-25 and miR-328, and perhaps other microRNAs, play a crucial role in Ca 2+ homeostasis by targeting the key regulator SERCA2a (Fig. 1 ) and, thus, may represent targets for therapeutic intervention against cardiac hypertrophy.
Neuronatin (NNAT) is an ER membrane protein (68) and a potential inhibitor of SERCA (69) . NNAT regulates intracellular Ca 2+ during adipogenesis of 3T3-L1 cells (70) and neurogenesis of embryonic stem cells (71) . miR-708 directly targets NNAT mRNA in metastatic breast cancer cells. The abundance of miR-708 is decreased in metastatic, as compared to nonmetastatic, breast cancer cells and inversely correlates with NNAT abundance. Stable overexpression of miR-708 in metastatic breast cancer cells decreases NNAT and promotes aberrant Ca 2+ reuptake in the ER after ATP-induced release, resulting in transiently increased cytosolic Ca 2+ concentration (72) . Cell migration, including that of metastatic tumor cells, relies on intracellular Ca 2+ (73) . Thus, miR-708 can regulate Ca 2+ homeostasis in breast cancer by suppressing NNAT abundance (72) (Fig. 1) , which could be relevant to metastatic cell migration. NNAT has structural similarities to phospholamban and sarcolipin, which are transmembrane proteins that inhibit SERCA (68, 74) , suggesting that NNAT may also antagonize SERCA activity. Likewise, phospholamban and sarcolipin might also be regulated by microRNAs, providing an additional layer of regulation of Ca 2+ homeostasis. Therefore, knowledge of how microRNAs can directly and indirectly regulate SERCA-dependent Ca 2+ homeostasis will be important for understanding normal physiology, cardiac hypertrophy, cancer metastasis, and potentially several other pathological conditions.
Ca
2+ Flux: Release from the ER Maintenance of ER homeostasis requires the regulated release of Ca 2+ from the ER by specialized channels and receptors. IP 3 Rs are important for the controlled transport of Ca 2+ out of the ER in response to IP 3 signaling (38). miR-786 targets ELO-2 mRNA, which encodes a fatty acid elongase involved in defecation in Caenorhabditis elegans (75, 76) . ELO-2 modulates the fatty acid composition of cellular membranes, mainly through addition of palmitate (76), which could change the activity of membrane proteins, including IP 3 Rs. miR-786 acts upstream of IP 3 Rs in worms, and miR-786-deficient worms have defects in the coordinated calcium oscillations in intestinal cells (75) , which are required for defecation and are caused by oscillatory IP 3 R-dependent Ca 2+ release from the ER (77, 78) . Thus, miR-786 may be a common and conserved mechanism of regulation of IP 3 R.
miR-133a also plays a role in IP 3 R-dependent Ca 2+ release. In rats, pressure overload induced by aortic banding causes hypertrophy of cardiomyocytes and increases the abundance of IP 3 R II in these cells (79) . IP 3 R II is an isoform of IP 3 R that is the predominant form found in cardiac cells (80) . mir-133a reduces the abundance of IP 3 R II in multiple cell types, including NRVMs and adult rat ventricular myocytes (ARVMs) in cell culture as well as mouse cardiomyocytes in vivo (81) . Moreover, miR-133a directly binds the mRNA encoding IP 3 R II in human embryonic kidney (HEK) 293 cells (81) . Thus, both miR-786 and miR-133a regulate the abundance of IP 3 R isoforms and, thereby, control Ca 2+ release from the ER. In addition to IP 3 Rs, RYRs are important for the regulated release of Ca 2+ (41) . In ARVMs, the muscle-specific microRNA miR-1 regulates RYR2, a cardiac-specific isoform of the RYR family, indirectly by targeting the B56a regulatory subunit of the protein phosphatase PP2A (82) . PP2A is a heterotrimeric protein that consists of a structural A domain, a regulatory B domain, and a catalytic C domain. The B regulatory subunits facilitate substrate specificity and subcellular localization of the phosphatase and are differentially expressed in different cell types (83) . Overexpression of miR-1 in cardiomyocytes causes hyperphosphorylation and activation of RYR2 by calmodulin-dependent protein kinase (CaMKII), which results in increased Ca 2+ release from the SR in response to caffeine (82) . Moreover, increased cytosolic Ca 2+ triggers Ca 2+ release from the SR (84) and is essential for the activation of muscle contractions (41) . Thus, activation of RYR2 is implicated in cardiac arrhythmia (85) . Overexpression of miR-1 in ARVMs decreases the abundance of B56a, causing inhibition of PP2A and increased activity of RYR2 (82 Direct inhibition by microRNAs through mRNA targeting is depicted with red bars.
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ATF6 in the heart of mice increases the abundance of UPR-associated genes including CALR (88) . CALR mRNA contains miR-455 binding sites, and microRNA sequencing identified that the abundance of miR-455 is decreased in the heart of mice with constitutively active ATF6 (90) . Exposing NRVMs to tunicamycin to induce the UPR ER or expressing constitutively active ATF6 in these cells decreases the abundance of miR-455 and increases the expression of CALR. Overexpression of pre-miR-455 decreases the abundance of CALR, whereas transfection with oligonucleotides that antagonize miR-455 increases abundance of CALR (90) . Thus, ER stress increases CALR, at least in part, by decreasing miR-455 (Fig. 2) . In embryonic stem cells, loss of CALR or depletion of ER Ca 2+ stores impairs the secretion of the Wnt-b-catenin signaling ligand WNT3A (91) and decreases the abundance of miR-302 (92) . The miR-302 family promotes cell cycle progression and maintenance of pluripotency in embryonic stem cells (93) . Thus, these data suggest that ER stress influences the abundance of multiple microRNAs that feed back to maintain ER Ca 2+ homeostasis and proteostasis. PDIs facilitate disulfide bond formation and isomerization of nascent proteins in the ER lumen (94) and are regulated by microRNAs. When ER Ca 2+ stores are empty, CALR binds and inhibits the activity of PDIs (95) (Fig. 2) . In addition, Ca 2+ binding directly promotes the activity of PDIs (96) . The expression of the gene encoding PDI-associated 6 (PDIA6) is increased in NIH-3T3 cells in response to various ER stress-inducing agents, including thapsigargin, tunicamycin, and brefeldin A. PDIA6 binds to IRE1a, and knockdown of PDIA6 decreases XBP1 splicing induced by thapsigargin, indicative of decreased IRE1a activity. The abundance of PDIA6 mRNA and protein is decreased by miR-322, implicating a direct interaction. The abundance of miR-322 is decreased in NIH-3T3 cells in response to depletion of ER Ca 2+ stores (97) . Thus, miR-322 likely supports ER Ca 2+ homeostasis by regulating the UPR ER sensor IRE1a through PDIA6. A disulfide bond at Cys (148) in the luminal domain of IRE1a promotes its activity. PDIA6 directly binds to Cys (148), reducing the disulfide bond and activity of IRE1a (98) . Thus, PDIA6 limits the UPR ER and maintains it in a physiological state, and this mechanism is likely modulated by miR-322. However, understanding whether miR-322 contributes to resistance to ER stress will require further investigation. BIP is involved in cardiovascular disease. The abundance of BIP is increased in cardiovascular diseases, including heart failure, ischemia, and stroke (100) (101) (102) . miR-181a is one of many microRNAs that change expression in response to ischemia or stroke in the brain (103, 104) . In a mouse stroke model, the expression of miR-181a is increased in the ischemic core and decreased in the surrounding tissue (penumbra). In contrast, BIP is decreased in the ischemic core and increased in the penumbra. Intracerebroventricular infusion of oligonucleotides that antagonize miR-181a reduces the size of the infarcted area in mice with strokes (105) , suggesting that inhibition of miR-181a in the brain is neuroprotective.
Various cancers exhibit increased ER stress, accompanied by increased abundance of BIP, compared to the respective unaffected tissue. BIP plays a critical role in tumor initiation, progression, and metastasis (106, 107) . In prostate, colon, and bladder cancer cell lines, three microRNAs-miR-30d, miR-181a, and miR-199a-5p-cooperate to suppress the translation of BIP. The expression of these microRNAs is decreased and inversely correlates with the expression of BIP in tumor samples from patients with these cancers. The cooperative binding of miR-30d, miR-181a, and miR-199a-5p to BIP mRNA decreases the abundance of BIP. On the contrary, binding of each of these microRNAs alone does not decrease BIP abundance. In C42B prostate cancer cells, ER stress induced by thapsigargin increases the abundance of BIP, and this effect is prevented by transfection with the precursors to miR-30d, miR-181a, and miR-199a-5p. Stable expression of these microRNAs in HCT116 colon cancer cells inhibits growth when the cells were grown as subcutaneous xenografts in mice (108) . These findings suggest that decreased abundance of miR-30d, miR-181a, and miR-199a-5p and the consequent increase in BIP and the UPR ER may be a mechanism that protects tumor cells from ER stress-dependent damage and thereby enables tumor cell survival.
Modulation of the UPR ER and Future Perspectives
The accumulation of misfolded proteins in the lumen of the ER causes induction of the UPR ER , which supports ER folding capacity by reducing protein translation and regulating the abundance of chaperones and enzymes that reestablish proteostasis (8, 9) . MicroRNAs that regulate or are expressed in response to activation of the stress sensors IRE1a, ATF6, and PERK are reviewed elsewhere (53, 54, 56) , outlining their important role in proteostasis. Here, we focused on microRNAs that inhibit proteins necessary for ER Ca 2+ homeostasis and thereby influence ER proteostasis (34) (35) (36) (Table 1) . Given the clear role of ER Ca 2+ for chaperone function and adaptive stress responses (34) (35) (36) , we consider microRNAs that finetune ER Ca 2+ homeostasis to be part of the proteostasis network. Prolonged ER stress induces proteolysis through multiple mechanisms, including autophagy, which is modulated by microRNAs (109) . For example, deletion of miR-34 in C. elegans increases the expression of autophagyrelated genes and extends life span (110) . Moreover, in mammalian cells, miR-34 directly binds the mRNA of autophagy-related gene 9 (Atg9). Atg9 is required for autophagy, and thus, miR-34 reduces autophagic flux (110) . The activation of autophagy requires the release of Ca 2+ from ER stores, mainly through IP 3 Rs, and from mitochondria (111) . Thus, the microRNAs that modulate ER Ca 2+ homeostasis, such as those described in this review, may also influence the activation of autophagy.
Chronic activation of the UPR ER causes cells to undergo apoptosis (112) . Different members of the B cell lymphoma 2 (BCL-2) protein family provide either pro-or antiapoptotic functions (113) . For example, the BCL-2 family members BAK and BAX promote mitochondrial outer membrane permeabilization and release of cytochrome c and other apoptotic factors into the cytosol (114) . In addition, BCL-2 and BCL-xL interact with IP 3 Rs to control Ca 2+ flux from ER to mitochondria (115) . Both processes promote formation of apoptosomes and activation of caspases, which induce apoptosis (116) . The abundance of miR-29 is increased by ER stress in neuronal tissue of amyotrophic lateral sclerosis (ALS) mice (117) and targets several BCL-2 family proteins (113) , suggesting that miR-29 links ER stress to apoptosis. Moreover, microRNAs that control the abundance of IP 3 Rs, thereby regulating Ca 2+ release from the ER, such as miR-786 and miR-133a (75, 81) , may indirectly influence the initiation of apoptosis.
In addition to the roles of microRNAs in ER Ca 2+ homeostasis (Table 1) , UPR ER , autophagy, and apoptosis, microRNAs also modulate other proteostasis pathways, including mitophagy (118), response to low temperatures (119), mTOR (mammalian target of rapamycin) signaling (120), and energy metabolism (121) . In contrast, there is little evidence for microRNAs that directly target key regulators of the UPS. Given the relevance of the UPS in many pathological and age-related conditions including Alzheimer's and Parkinson's diseases, it may be particularly important to study whether and how microRNAs affect this process. In multicellular organisms, the induction of specific proteostasis pathways is often regulated non-cell autonomously, indicating extensive physiological crosstalk between different tissues (122) . For example, the heat shock response in C. elegans depends on specific thermosensory neurons and downstream signaling that affects nonneuronal tissues. Functional inhibition of these neurons abrogates the ability to sense ambient temperature and the associated behavioral responses and prevents the systemic heat shock response, resulting in decreased thermal tolerance (123, 124) . In addition, activation of IRE1 and subsequent XBP1 splicing in neuronal cells can induce the UPR ER in the worm intestine. Expression of constitutively active XBP1 in worm neurons inhibits age-related decline of the UPR ER and increases resistance to ER stress, prolonging life span (14) . Thus, although the microRNAs discussed in this review regulate target mRNAs within diverse tissues, such as cardiac and smooth muscle (60, 62, 66, 82) , intestine (75) , and neuronal cells (105) , it is possible that these microRNAs also coordinate ER Ca 2+ homeostasis and proteostasis among organs and, thus, contribute to systemic stress responses.
Concluding Remarks
In this review, we highlight microRNAs that regulate key components in ER Ca 2+ homeostasis (Table 1) , including transmembrane channels and receptors that control Ca 2+ flux across the ER membrane and Ca 2+ binding, ER-resident chaperones important for ER Ca 2+ storage. These microRNAs and their targets were mainly characterized in pathological conditions, and future work is needed to elucidate whether these relationships have a more general physiological relevance. Furthermore, this evidence suggests that some of these microRNAs may be putative therapeutic targets in disease prevention or treatment, especially with regard to heart failure. In conclusion, it is clear that microRNAs act at different levels to regulate ER Ca 2+ homeostasis and maintain optimal luminal Ca 2+ conditions and thus finetune ER proteostasis mechanisms.
